You just read:

CytRx Presents Positive Interim Results from On-going Phase 1b/2 Aldoxorubicin Combination Clinical Trial at the 2016 CTOS Annual Meeting

News provided by

CytRx Corporation

Nov 11, 2016, 09:00 ET